Skip to main content
OpenTrials

Clinical trial condition

Castration-resistant Prostate Cancer

Explore clinical trials studying Castration-resistant Prostate Cancer. Study availability and eligibility vary by location and protocol.

64 public trials 13 recruiting studies
Refine in advanced search Browse all conditions

Castration-resistant Prostate Cancer trial results

Completed

A Study to Evaluate Once-Daily Oral VT-464 in Patients With Castration-Resistant Prostate Cancer

NCT02361086

Conditions
CRPC, Castration-resistant Prostate Cancer
Locations
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Urology Cancer Center Omaha, Nebraska, United States
  • Duke University Medical Center Durham, North Carolina, United States
  • Carolina Urologic Research Center Myrtle Beach, South Carolina, United States
View Trial Details
Completed

Safety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based Chemotherapy

NCT00974311

Conditions
Castration-resistant Prostate Cancer, Genital Diseases, Genital Diseases, Male, +8 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Premiere Oncology of Arizona Scottsdale, Arizona, United States
View all 249 locations
View Trial Details
Active, Not Recruiting

Comparing Continuation or De-escalation of Bone Modifying Agents (BMA) in Patients Treated for Over 2 Years for Bone Metastases From Either Breast or Castration-resistant Prostate Cancer

NCT04549207

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations
  • William Osler Health System Brampton, Ontario, Canada
  • London Health Sciences Centre London, Ontario, Canada
  • Southlake Regional Health Centre Newmarket, Ontario, Canada
  • The Ottawa Hospital Cancer Centre Ottawa, Ontario, Canada
View Trial Details
Active, Not Recruiting

Study of Cabozantinib and Nivolumab in Metastatic Castration Resistant Prostate Cancer

NCT05502315

Conditions
Castration-resistant Prostate Cancer, Metastatic Cancer, Neoplasm Metastasis, +4 more
Locations
  • University of California San Diego La Jolla, California, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • University of Texas Southwestern Medical Center Dallas, Texas, United States
  • University of Wisconsin Madison, Wisconsin, United States
View Trial Details
Active, Not Recruiting

Management of Oligoprogressive Castration Resistant Prostate Cancer (PCS X)

NCT04070209

Conditions
Castration-resistant Prostate Cancer, Genital Diseases, Genital Diseases, Male, +9 more
Locations
  • Prostate Cancer Centre Calgary, Alberta, Canada
  • Centre of Applied Urology Research Halifax, Nova Scotia, Canada
  • St. Joseph's Healthcare Hamilton Hamilton, Ontario, Canada
  • Hôpital de Gatineau Gatineau, Quebec, Canada
View Trial Details

Related conditions